This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Nov 1;154(5):e2024068359.

doi: 10.1542/peds.2024-068359.

Is Now the Time for Clonidine as a First-Line Agent for Neonatal Opioid Withdrawal Syndrome?

Elisha M Wachman¹, Hayley Friedman²

Affiliations

Affiliations

¹ Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
² Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.

PMID: 39403055
DOI: 10.1542/peds.2024-068359

Editorial

Is Now the Time for Clonidine as a First-Line Agent for Neonatal Opioid Withdrawal Syndrome?

Elisha M Wachman et al. Pediatrics. 2024.

. 2024 Nov 1;154(5):e2024068359.

doi: 10.1542/peds.2024-068359.

Authors

Elisha M Wachman¹, Hayley Friedman²

Affiliations

¹ Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
² Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.

PMID: 39403055
DOI: 10.1542/peds.2024-068359

No abstract available

PubMed Disclaimer

Comment on

Clonidine as Monotherapy for Neonatal Opioid Withdrawal Syndrome: A Randomized Trial.
Bada HS, Westgate PM, Sithisarn T, Yolton K, Charnigo R, Pourcyrous M, Tang F, Gibson J, Shearer-Miller J, Giannone P, Leggas M. Bada HS, et al. Pediatrics. 2024 Nov 1;154(5):e2023065610. doi: 10.1542/peds.2023-065610. Pediatrics. 2024. PMID: 39403061 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems